Amgen Inc. (AMGN) stock analysis

In our weekly check, Amgen Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2.

About Amgen Inc.

Amgen Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as AMGN.

What our checks show for AMGN

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-02

Similar companies

AZN · NVS · GILD · NVO · MRK · PFE

Questions

What grade does Amgen Inc. (AMGN) have?

In our weekly check, Amgen Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of AMGN stock?

This week's biggest flags for Amgen Inc.: High debt, Slow recovery after falls, Gross margin falling. In total 5 of 25 checks show a warning or a red flag.

What does Amgen Inc. do?

Amgen Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as AMGN.

When does Amgen Inc. report earnings next?

The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis